The Nagoya-based distributor saw its revenue climb to ¥1.89 trillion, up from ¥1.84 trillion in the same period a year earlier. This topline growth reflects steady demand within the Japanese healthcare supply chain, though the company’s core profitability metrics showed signs of tightening. Operating profit fell to ¥27.23 billion, a decrease from the ¥29.80 billion reported in the prior year.
In section Market Quotes
Suzuken Net Profit Edges Higher Despite Operating Margin Pressure
Japanese pharmaceutical wholesaler Suzuken Co. Ltd. reported a net profit of ¥31.01 billion for the nine months ended Dec. 31, according to its latest financial filing, narrowly outpacing the previous year’s performance despite a contraction in operating income.
Diverging Profitability Metrics
The company’s pretax profit also experienced a year-on-year decline, sliding to ¥29.32 billion from ¥30.91 billion. Despite these pressures on the operating side, Suzuken managed to increase its bottom-line earnings and significantly boost its per-share value. Earnings per share rose to ¥439.74, compared to ¥398.44 in the previous period, according to the company's financial statement.The results, which are based on Japanese accounting standards, highlight the following key financial shifts for the nine-month period:
- Total revenue increased to ¥1.89 trillion from ¥1.84 trillion.
- Operating profit contracted to ¥27.23 billion.
- Net profit rose to ¥31.01 billion from ¥30.67 billion.
Comments (0)
No comments yet. Be the first!